Trial Profile
Eculizumab in patients with classic PNH: A cost effectivity study
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 22 May 2015
Price :
$35
*
At a glance
- Drugs Eculizumab (Primary)
- Indications Paroxysmal nocturnal haemoglobinuria
- Focus Therapeutic Use
- 16 Oct 2014 New trial record